Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Silybin is the most bioactive flavonolignan compound in milk thistle extract, comprising 50-70% of silymarin complex. It functions as a potent hepatoprotective agent by stabilizing hepatocyte membranes and reducing oxidative stress through antioxidant pathways.
Origin & History
Silybin (also known as silibinin) is the major active flavonolignan constituent of silymarin, a standardized extract from the seeds of the milk thistle plant (Silybum marianum), a thistle native to the Mediterranean region. It is extracted via solvent-based methods from the plant's ripe seeds followed by purification, with standardized extracts containing 70-80% flavonolignans, of which silybin comprises about 50-60%.
Research Narrative (Provisional)
Large Phase II trials in NASH patients (NCT00680407, PMID: 31536511; NCT02006498, PMID: 28419855) using 420-2100 mg/day silymarin showed no significant improvement in primary endpoints, though a meta-analysis (PMID: 29245314) found modest transaminase reductions. A triple-blind RCT in breast cancer patients (PMID: 33861657) suggested potential hepatoprotective effects during chemotherapy.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Silybin is a pure bioactive flavonolignan compound, not a whole food, and therefore has no meaningful macronutrient, vitamin, mineral, or fiber profile in the traditional nutritional sense. Key compositional details: Silybin is the primary active constituent (~50-70%) of silymarin, the standardized extract from milk thistle (Silybum marianum) seeds. It exists as two diastereomers: Silybin A and Silybin B, with Silybin B generally showing greater biological activity. Molecular weight: 482.44 g/mol. As a flavonolignan, it combines a flavonoid (taxifolin) and a lignan (coniferyl alcohol) moiety. Typical therapeutic doses studied range from 94 mg to 576 mg/day of silybin equivalents. Bioavailability is a significant limiting factor: conventional silybin has poor oral bioabsorption (~0.73-1% in some models) due to low water solubility and limited intestinal permeability. Enhanced delivery forms show markedly improved bioavailability: Silybin-phosphatidylcholine complex (Siliphos/IdB 1016) demonstrates 4-10x greater absorption compared to standard silybin; nanoparticle and phytosome formulations further improve plasma concentrations. Peak plasma concentration (Cmax) in phosphatidylcholine complex formulations reached approximately 0.5-1.0 µg/mL at doses of 360 mg. Silybin undergoes hepatic phase II conjugation (glucuronidation and sulfation) and is primarily excreted via bile. No caloric contribution is expected at therapeutic doses.
Reported Mechanism (Provisional)
Silybin stabilizes hepatocyte cell membranes by binding to phospholipids and preventing lipid peroxidation. It activates nuclear factor erythroid 2-related factor 2 (Nrf2) pathways to enhance antioxidant enzyme production including glutathione peroxidase and superoxide dismutase. The compound also inhibits nuclear factor kappa B (NF-κB) activation, reducing inflammatory cytokine production in liver tissue.
Clinical Narrative (Provisional)
A meta-analysis of 8 randomized controlled trials demonstrated silybin's efficacy in non-alcoholic fatty liver disease, reducing AST levels by 6.57 U/L and ALT levels by 9.16 U/L compared to placebo. One RCT in breast cancer patients showed reduced hepatic involvement on ultrasonography during chemotherapy treatment. Evidence quality is moderate for liver enzyme reduction but preliminary for chemotherapy-induced hepatotoxicity prevention. Most studies used silybin-phosphatidylcholine complexes at doses ranging from 376-800mg daily.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.